<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03191656</url>
  </required_header>
  <id_info>
    <org_study_id>1701</org_study_id>
    <nct_id>NCT03191656</nct_id>
  </id_info>
  <brief_title>REDUCE LAP-HF III Corvia Protocol 1701</brief_title>
  <acronym>REDUCELAPHFIII</acronym>
  <official_title>A Post-Market Clinical Follow-up Study to Evaluate the Corvia Medical, Inc. InterAtrial Shunt Device - IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corvia Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corvia Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a post market trial to be conducted at several sites in Germany. The device has CE
      approval in the EU. The purpose of this observational registry is to collect post market data
      in consecutive patients treated with the IASD System II, to further evaluate efficacy, safety
      and quality of life outcomes as a new treatment for patients with heart failure in a &quot;real
      world&quot; practice setting.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 12, 2017</start_date>
  <completion_date type="Anticipated">July 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serious Adverse Events</measure>
    <time_frame>30 days</time_frame>
    <description>Device and or procedure related serious adverse cardiac events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Life Improvement (KCCQ score)</measure>
    <time_frame>12 months</time_frame>
    <description>Improvement in KCCQ score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>New York Heart Classification</measure>
    <time_frame>12 months</time_frame>
    <description>Improvement in NYHA Classification</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Life Improvement (EQ5D)</measure>
    <time_frame>12 months</time_frame>
    <description>Improvement in EQ5D score</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Heart Failure</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IASD Implant</intervention_name>
    <description>Implantation of the IASD device using trans-septal puncture and the IASD system</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with heart failure with preserved (HFpEF) or mid-range ejection fraction (HFmrEF)
        with elevated left atrial pressures, who remain symptomatic despite standard Guideline
        Directed Medical Therapy (GDMT), in accordance with CE-mark approved labeling.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        This is a post market registry so no criteria requirements (only recommendations).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jan Komtebedde, DVM</last_name>
    <phone>978-654-6113</phone>
    <email>jkomtebedde@corviamedical.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jennifer Seale, MPH</last_name>
    <phone>978-654-6124</phone>
    <email>jseale@corviamedical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinikum Lippe GmbH</name>
      <address>
        <city>Detmold</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Gielen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Elisabeth-Krankenhaus Essen</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Bruder, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitäts Klinikum Halle</name>
      <address>
        <city>Halle</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Noutsias, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Vincenz-Kranenhaus</name>
      <address>
        <city>Paderborn</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Goette, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Paul Gerhardt Stift - Unfallstation</name>
      <address>
        <city>Wittenberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franz Kleber, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bürgelspital Solothurn</name>
      <address>
        <city>Solothurn</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rolf Vogel, Prof</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>June 12, 2017</study_first_submitted>
  <study_first_submitted_qc>June 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2017</study_first_posted>
  <last_update_submitted>April 16, 2019</last_update_submitted>
  <last_update_submitted_qc>April 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

